Clinical Trial: Efficacy and safety comparison of endoscopic ultrasound-guided lauromacrogol ablation versus saline lavage followed by paclitaxel and gemcitabine injection for the treatment of pancreatic cystic neoplasms: A multicenter, non-inferiority, single-blind, randomized controlled trial (ESLPN protocol) (China)

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and safety comparison of endoscopic ultrasound-guided lauromacrogol ablation versus saline lavage followed by paclitaxel and gemcitabine injection for the treatment of pancreatic cystic neoplasms: A multicenter, non-inferiority, single-blind, randomized controlled trial (ESLPN protocol)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129506

Registration Time: 2026/08/05

Type: Interventional study

Primary Sponsor: Chinese PLA General Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=331202

Published by HT Digital Content Services with p...